{"id":"https://openalex.org/W2061669920","doi":"https://doi.org/10.1185/03007995.2012.761600","title":"A randomized, double-blind trial of 2.5 mg and 5 mg vortioxetine (Lu AA21004) versus placebo for 8 weeks in adults with major depressive disorder","display_name":"A randomized, double-blind trial of 2.5 mg and 5 mg vortioxetine (Lu AA21004) versus placebo for 8 weeks in adults with major depressive disorder","alternate_titles":[],"publication_year":2012,"publication_date":"2012-12-20","ids":{"openalex":"https://openalex.org/W2061669920","doi":"https://doi.org/10.1185/03007995.2012.761600","mag":"2061669920","pmid":"https://pubmed.ncbi.nlm.nih.gov/23252878"},"language":"en","primary_location":{"id":"doi:10.1185/03007995.2012.761600","doi":"https://doi.org/10.1185/03007995.2012.761600","is_oa":false,"landing_page_url":"https://doi.org/10.1185/03007995.2012.761600","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2061669920"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5112910391","display_name":"Atul R. Mahableshwarkar","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]},{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP","US"],"is_corresponding":true,"raw_author_name":"Atul R. Mahableshwarkar","raw_affiliation_strings":["Takeda Global Research and Development Center, USA","Takeda Global Research and Development Center, One Takeda Parkway, Deerfield, IL 60015, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Global Research and Development Center, USA","institution_ids":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]},{"raw_affiliation_string":"Takeda Global Research and Development Center, One Takeda Parkway, Deerfield, IL 60015, USA","institution_ids":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024369212","display_name":"Paula L. Jacobsen","orcid":"https://orcid.org/0000-0003-0216-655X","observed_orcids":["https://orcid.org/0000-0003-0216-655X"]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]},{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP","US"],"is_corresponding":false,"raw_author_name":"Paula L. Jacobsen","raw_affiliation_strings":["Takeda Global Research and Development Center, USA","Takeda Global Research and Development Center Deerfield, ILUSA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Global Research and Development Center, USA","institution_ids":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]},{"raw_affiliation_string":"Takeda Global Research and Development Center Deerfield, ILUSA","institution_ids":["https://openalex.org/I4210140176"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5068791484","display_name":"Yinzhong Chen","orcid":"https://orcid.org/0009-0004-5224-4215","observed_orcids":["https://orcid.org/0009-0004-5224-4215"]},"institutions":[{"id":"https://openalex.org/I4210140176","display_name":"Takeda (United States)","ror":"https://ror.org/03bygaq51","country_code":"US","type":"company","lineage":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]},{"id":"https://openalex.org/I44892455","display_name":"Takeda (Japan)","ror":"https://ror.org/04hjbmv12","country_code":"JP","type":"company","lineage":["https://openalex.org/I44892455"]}],"countries":["JP","US"],"is_corresponding":false,"raw_author_name":"Yinzhong Chen","raw_affiliation_strings":["Takeda Global Research and Development Center, USA","Takeda Global Research and Development Center Deerfield, ILUSA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Takeda Global Research and Development Center, USA","institution_ids":["https://openalex.org/I4210140176","https://openalex.org/I44892455"]},{"raw_affiliation_string":"Takeda Global Research and Development Center Deerfield, ILUSA","institution_ids":["https://openalex.org/I4210140176"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5112910391"],"corresponding_institution_ids":["https://openalex.org/I4210140176","https://openalex.org/I44892455"],"apc_list":null,"apc_paid":null,"fwci":11.4388,"has_fulltext":false,"cited_by_count":146,"citation_normalized_percentile":{"value":0.9917466,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":100},"biblio":{"volume":"29","issue":"3","first_page":"217","last_page":"226"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T13118","display_name":"Psychological Treatments and Disorders","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/vortioxetine","display_name":"vortioxetine","score":0.7649999856948853},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.9919999837875366},{"id":"https://openalex.org/keywords/antidepressant-efficacy","display_name":"antidepressant efficacy","score":0.8050000071525574},{"id":"https://openalex.org/keywords/duloxetine","display_name":"duloxetine","score":0.8500000238418579},{"id":"https://openalex.org/keywords/sexual-dysfunction","display_name":"sexual dysfunction","score":0.6859999895095825},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.722000002861023},{"id":"https://openalex.org/keywords/serotonin-transporter-inhibition","display_name":"serotonin transporter inhibition","score":0.6859999895095825},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.6859999895095825},{"id":"https://openalex.org/keywords/remission-rate","display_name":"remission rate","score":0.6539999842643738},{"id":"https://openalex.org/keywords/antidepressant-tolerability","display_name":"antidepressant tolerability","score":0.550000011920929},{"id":"https://openalex.org/keywords/hamilton-depression-rating-scale","display_name":"Hamilton Depression Rating Scale","score":0.48899999260902405},{"id":"https://openalex.org/keywords/clinical-global-impression-scale","display_name":"Clinical Global Impression Scale","score":0.8199999928474426},{"id":"https://openalex.org/keywords/responder-rate","display_name":"responder rate","score":0.42500001192092896},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.35499998927116394},{"id":"https://openalex.org/keywords/xerostomia","display_name":"xerostomia","score":0.9319999814033508}],"concepts":[{"id":"https://openalex.org/C2778034309","wikidata":"https://www.wikidata.org/wiki/Q3563148","display_name":"Vortioxetine","level":4,"score":0.9885725378990173},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.790183961391449},{"id":"https://openalex.org/C2780764818","wikidata":"https://www.wikidata.org/wiki/Q411932","display_name":"Duloxetine","level":3,"score":0.7091166973114014},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6795202493667603},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6197059154510498},{"id":"https://openalex.org/C2780051608","wikidata":"https://www.wikidata.org/wiki/Q42844","display_name":"Major depressive disorder","level":3,"score":0.5799408555030823},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.5055487155914307},{"id":"https://openalex.org/C58732023","wikidata":"https://www.wikidata.org/wiki/Q770260","display_name":"Partial agonist","level":4,"score":0.5007572174072266},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4734247028827667},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.46618813276290894},{"id":"https://openalex.org/C2776000289","wikidata":"https://www.wikidata.org/wiki/Q5133761","display_name":"Clinical Global Impression","level":4,"score":0.4653196334838867},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3958829641342163},{"id":"https://openalex.org/C2778938600","wikidata":"https://www.wikidata.org/wiki/Q389934","display_name":"Agonist","level":3,"score":0.3406186103820801},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.32645678520202637},{"id":"https://openalex.org/C2780733359","wikidata":"https://www.wikidata.org/wiki/Q331769","display_name":"Mood","level":2,"score":0.26398223638534546},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.25277507305145264},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.08477911353111267},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000068736","descriptor_name":"Duloxetine Hydrochloride","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000078784","descriptor_name":"Vortioxetine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D010879","descriptor_name":"Piperazines","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D010919","descriptor_name":"Placebos","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012735","descriptor_name":"Sexual Dysfunction, Physiological","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D013440","descriptor_name":"Sulfides","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D013440","descriptor_name":"Sulfides","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013440","descriptor_name":"Sulfides","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D013876","descriptor_name":"Thiophenes","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D059020","descriptor_name":"Suicidal Ideation","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1185/03007995.2012.761600","doi":"https://doi.org/10.1185/03007995.2012.761600","is_oa":false,"landing_page_url":"https://doi.org/10.1185/03007995.2012.761600","pdf_url":null,"source":{"id":"https://openalex.org/S206643269","display_name":"Current Medical Research and Opinion","issn_l":"0300-7995","issn":["0300-7995","1473-4877"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-d","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current Medical Research and Opinion","raw_type":"journal-article"},{"id":"pmid:23252878","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/23252878","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Current medical research and opinion","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W119739424","https://openalex.org/W181499380","https://openalex.org/W1731053727","https://openalex.org/W1967378279","https://openalex.org/W1978199985","https://openalex.org/W1987514922","https://openalex.org/W1987560991","https://openalex.org/W1991606546","https://openalex.org/W1992333267","https://openalex.org/W2011606125","https://openalex.org/W2019024524","https://openalex.org/W2020448388","https://openalex.org/W2028306465","https://openalex.org/W2031349278","https://openalex.org/W2036812642","https://openalex.org/W2041144155","https://openalex.org/W2048026164","https://openalex.org/W2051453284","https://openalex.org/W2054766240","https://openalex.org/W2059274457","https://openalex.org/W2066283885","https://openalex.org/W2070468494","https://openalex.org/W2071735605","https://openalex.org/W2084177902","https://openalex.org/W2085758661","https://openalex.org/W2087564554","https://openalex.org/W2089659183","https://openalex.org/W2120377396","https://openalex.org/W2124216937","https://openalex.org/W2129152730","https://openalex.org/W2137296158","https://openalex.org/W2159271064","https://openalex.org/W2160836626","https://openalex.org/W2164182651","https://openalex.org/W2167761850","https://openalex.org/W2170684975","https://openalex.org/W2220387563","https://openalex.org/W2225684373","https://openalex.org/W4256723936"],"related_works":["https://openalex.org/W2054766240","https://openalex.org/W1986102787","https://openalex.org/W810408096","https://openalex.org/W2001782289","https://openalex.org/W845297282","https://openalex.org/W2752826413","https://openalex.org/W2303297560","https://openalex.org/W2338993357","https://openalex.org/W4386888577","https://openalex.org/W2243818691"],"abstract_inverted_index":{"OBJECTIVE:":[0],"Vortioxetine":[1],"(Lu":[2],"AA21004)":[3],"is":[4,14],"an":[5],"investigational":[6],"antidepressant.":[7],"In":[8,261],"vitro":[9],"studies":[10],"indicate":[11],"that":[12],"vortioxetine":[13,47,73,135,180,229,249,252,273,311],"a":[15],"5-HT(3),":[16],"5-HT(7),":[17],"and":[18,29,40,44,110,120,169,186,234,245,256,303],"5-HT(1D)":[19],"receptor":[20,23,27],"antagonist,":[21],"5-HT(1B)":[22],"partial":[24],"agonist,":[25],"5-HT(1A)":[26],"agonist":[28],"inhibitor":[30],"of":[31,42,51,68,134,237,264,305,310],"the":[32,38,49,92,125,179,248],"5-HT":[33],"transporter.":[34],"This":[35,315],"trial":[36,306,316],"assessed":[37],"efficacy":[39],"tolerability":[41],"2.5":[43,166,250,274],"5":[45,76,172,253,277],"mg":[46,167,173,275,278],"for":[48,116,228,269],"treatment":[50,70,197],"MDD.":[52],"RESEARCH":[53],"DESIGN":[54],"AND":[55],"METHODS:":[56],"Adults":[57],"(N":[58],"=":[59,208],"611)":[60],"with":[61,71,138,200,266,272,290],"MDD":[62,267,299],"were":[63,114,136,148,158,189,230,241,285,312],"randomized":[64],"to":[65,145],"8":[66,153,270],"weeks":[67,271],"double-blind":[69],"placebo,":[72,163],"(2.5":[74],"or":[75,78,276],"mg)":[77],"active":[79],"reference":[80],"(duloxetine":[81],"60":[82],"mg).":[83],"The":[84,224],"primary":[85],"measure":[86],"was":[87,198],"change":[88],"from":[89,156,194],"baseline":[90,157],"in":[91,140,178,202,215,247,282],"24-item":[93],"Hamilton":[94],"Depression":[95],"Scale":[96],"(HAM-D24).":[97],"Secondary":[98,175],"endpoints":[99],"included":[100],"responder":[101,183],"rate,":[102,184,188],"Clinical":[103],"Global":[104],"Impression":[105],"Scale-Global":[106],"Improvement":[107],"scale":[108],"(CGI-I),":[109],"remission":[111,187],"rate.":[112],"Participants":[113],"monitored":[115],"adverse":[117],"events":[118],"(AEs),":[119],"treatment-emergent":[121],"sexual":[122,238],"dysfunction":[123,239],"using":[124],"Arizona":[126],"Sexual":[127],"Experiences":[128],"(ASEX)":[129,240],"scale.":[130],"RESULTS:":[131],"Both":[132,308],"doses":[133,309],"associated":[137,199],"declines":[139,201],"HAM-D24":[141,203],"total":[142,204],"scores":[143],"compared":[144,289],"placebo":[146,220,257],"but":[147],"not":[149,191,286],"statistically":[150,287],"significant.":[151],"At":[152],"weeks,":[154],"changes":[155],"[mean":[159],"(SE)]:":[160],"-10.50":[161],"(0.76)":[162],"-12.04":[164],"(0.74)":[165,171],"vortioxetine,":[168],"-11.08":[170],"vortioxetine.":[174],"outcome":[176,217],"measures":[177,218],"groups,":[181,258],"including":[182,296],"CGI-I,":[185],"also":[190],"significantly":[192],"different":[193],"placebo.":[195,291],"Duloxetine":[196],"score":[205],"[-13.47(0.75);":[206],"p":[207],"0.005]":[209],"as":[210,212],"well":[211,313],"significant":[213,288],"improvements":[214],"secondary":[216],"versus":[219],"(p":[221],"\u2264":[222],"0.05).":[223],"most":[225],"common":[226],"AEs":[227],"nausea,":[231],"dry":[232],"mouth,":[233],"headache.":[235],"Rates":[236],"51.0%,":[242],"37.5%,":[243],"46.9%,":[244],"33.3%":[246],"mg,":[251,254],"duloxetine,":[255],"respectively.":[259],"CONCLUSIONS:":[260],"this":[262],"study":[263],"adults":[265],"treated":[268],"per":[279],"day,":[280],"reductions":[281],"depression":[283],"symptoms":[284],"Study":[292],"limitations":[293],"are":[294],"discussed,":[295],"patient":[297],"characteristics,":[298],"severity,":[300],"drug":[301],"dosing,":[302],"aspects":[304],"design.":[307],"tolerated.":[314],"has":[317],"been":[318],"registered":[319],"at":[320],"clinicaltrials.gov":[321],"#NCT00672620.":[322]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2061669920","counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2025,"cited_by_count":9},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":9},{"year":2021,"cited_by_count":10},{"year":2020,"cited_by_count":3},{"year":2019,"cited_by_count":13},{"year":2018,"cited_by_count":8},{"year":2017,"cited_by_count":12},{"year":2016,"cited_by_count":16},{"year":2015,"cited_by_count":27},{"year":2014,"cited_by_count":17},{"year":2013,"cited_by_count":7}],"updated_date":"2026-11-17T12:49:18.490984","created_date":"2016-06-24T00:00:00"}
